Can-Fite Biopharma Ltd - ADR
|Market Cap (Intraday)||38.35M|
|2yr Forward PE||N/A|
Can-Fite Biopharma Ltd - ADR Stock, ASE:CANF
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for cancer and inflammatory diseases. Its product pipeline includes Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.